|
þ
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
04-3536131
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(IRS Employer Identification No.)
|
45 First Avenue
|
|
Waltham, Massachusetts
|
02451
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Large accelerated filer
o
|
Accelerated filer
o
|
Non –accelerated filer
o
|
Smaller reporting company
x
|
Title of each class
|
|
Outstanding, March 31, 2014
|
Common Stock, $0.001 par value
|
|
15,161,600
|
PART I
- FINANCIAL INFORMATION
|
||
|
|
|
|
||
|
||
|
||
|
||
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2014
|
|
December 31, 2013
|
||||
ASSETS
|
|
|
|
|
|
||
Current assets:
|
|
|
|
|
|
||
Cash and cash equivalents
|
$
|
1,946,891
|
|
|
$
|
7,713,899
|
|
Short-term investments, restricted
|
583,720
|
|
|
—
|
|
||
Accounts receivable, net
|
4,249,889
|
|
|
3,740,885
|
|
||
Unbilled revenue
|
718,108
|
|
|
646,398
|
|
||
Inventory, net
|
3,473,257
|
|
|
3,343,793
|
|
||
Due from related party
|
306,305
|
|
|
—
|
|
||
Deferred financing costs
|
134,234
|
|
|
140,433
|
|
||
Prepaid and other current assets
|
475,888
|
|
|
340,013
|
|
||
Total current assets
|
11,888,292
|
|
|
15,925,421
|
|
||
Property, plant and equipment, net
|
634,560
|
|
|
638,026
|
|
||
Intangible assets, net
|
969,777
|
|
|
953,327
|
|
||
Goodwill
|
40,870
|
|
|
40,870
|
|
||
Other assets
|
40,425
|
|
|
72,425
|
|
||
TOTAL ASSETS
|
$
|
13,573,924
|
|
|
$
|
17,630,069
|
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
||
Current liabilities:
|
|
|
|
|
|
||
Demand notes payable and line of credit, related party
|
$
|
—
|
|
|
$
|
2,950,000
|
|
Senior convertible promissory note, related party
|
3,000,000
|
|
|
3,000,000
|
|
||
Accounts payable
|
1,864,044
|
|
|
2,338,046
|
|
||
Accrued expenses
|
1,407,452
|
|
|
1,139,554
|
|
||
Deferred revenue
|
1,008,248
|
|
|
613,915
|
|
||
Due to related party
|
—
|
|
|
119,667
|
|
||
Interest payable, related party
|
—
|
|
|
198,450
|
|
||
Total current liabilities
|
7,279,744
|
|
|
10,359,632
|
|
||
Long-term liabilities:
|
|
|
|
|
|
||
Deferred revenue, net of current portion
|
262,701
|
|
|
204,544
|
|
||
Total liabilities
|
7,542,445
|
|
|
10,564,176
|
|
||
|
|
|
|
||||
Commitments and contingencies (Note 5)
|
|
|
|
|
|
||
|
|
|
|
||||
Stockholders’ equity:
|
|
|
|
|
|
||
Tecogen Inc. shareholders’ equity:
|
|
|
|
|
|
||
Common stock, $0.001 par value; 100,000,000 shares authorized; 15,161,600 and 15,155,200 issued and outstanding at March 31, 2014 and December 31, 2013, respectively
|
15,162
|
|
|
15,155
|
|
||
Additional paid-in capital
|
22,508,013
|
|
|
22,463,996
|
|
||
Accumulated deficit
|
(16,229,257
|
)
|
|
(15,209,212
|
)
|
||
Total Tecogen Inc. stockholders’ equity
|
6,293,918
|
|
|
7,269,939
|
|
||
Noncontrolling interest
|
(262,439
|
)
|
|
(204,046
|
)
|
||
Total stockholders’ equity
|
6,031,479
|
|
|
7,065,893
|
|
||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
|
$
|
13,573,924
|
|
|
$
|
17,630,069
|
|
|
2014
|
|
2013
|
||||
Revenues
|
|
|
|
|
|
||
Products
|
$
|
1,944,776
|
|
|
$
|
2,052,665
|
|
Services
|
2,270,981
|
|
|
1,993,653
|
|
||
|
4,215,757
|
|
|
4,046,318
|
|
||
Cost of sales
|
|
|
|
|
|
||
Products
|
1,404,439
|
|
|
1,588,668
|
|
||
Services
|
1,385,092
|
|
|
1,345,686
|
|
||
|
2,789,531
|
|
|
2,934,354
|
|
||
|
|
|
|
||||
Gross profit
|
1,426,226
|
|
|
1,111,964
|
|
||
|
|
|
|
||||
Operating expenses
|
|
|
|
|
|
||
General and administrative
|
2,052,126
|
|
|
1,791,703
|
|
||
Selling
|
421,620
|
|
|
279,370
|
|
||
|
2,473,746
|
|
|
2,071,073
|
|
||
|
|
|
|
||||
Loss from operations
|
(1,047,520
|
)
|
|
(959,109
|
)
|
||
|
|
|
|
||||
Other income (expense)
|
|
|
|
|
|
||
Interest and other income
|
3,085
|
|
|
3,946
|
|
||
Interest expense
|
(34,770
|
)
|
|
(23,377
|
)
|
||
|
(31,685
|
)
|
|
(19,431
|
)
|
||
|
|
|
|
||||
Loss before income taxes
|
(1,079,205
|
)
|
|
(978,540
|
)
|
||
Consolidated net loss
|
(1,079,205
|
)
|
|
(978,540
|
)
|
||
|
|
|
|
||||
Less: Loss attributable to the noncontrolling interest
|
59,160
|
|
|
118,147
|
|
||
Net loss attributable to Tecogen Inc.
|
$
|
(1,020,045
|
)
|
|
$
|
(860,393
|
)
|
|
|
|
|
||||
Net loss per share - basic and diluted
|
$
|
(0.07
|
)
|
|
$
|
(0.07
|
)
|
|
|
|
|
||||
Weighted average shares outstanding - basic and diluted
|
14,796,413
|
|
|
13,212,894
|
|
|
Tecogen Inc.
|
|
|
|
|
||||||||||||||
|
Common
Stock
0.001
Par Value
|
|
Additional
Paid-In
Capital
|
|
Accumulated
Deficit
|
|
Noncontrolling
Interest
|
|
Total
|
||||||||||
Balance at December 31, 2013
|
$
|
15,155
|
|
|
$
|
22,463,996
|
|
|
$
|
(15,209,212
|
)
|
|
$
|
(204,046
|
)
|
|
$
|
7,065,893
|
|
Sale of restricted common stock
|
2
|
|
|
6,298
|
|
|
—
|
|
|
—
|
|
|
6,300
|
|
|||||
Exercise of stock options
|
5
|
|
|
5,995
|
|
|
—
|
|
|
—
|
|
|
6,000
|
|
|||||
Stock based compensation expense
|
—
|
|
|
31,724
|
|
|
—
|
|
|
767
|
|
|
32,491
|
|
|||||
Net loss
|
—
|
|
|
—
|
|
|
(1,020,045
|
)
|
|
(59,160
|
)
|
|
(1,079,205
|
)
|
|||||
Balance at March 31, 2014
|
$
|
15,162
|
|
|
$
|
22,508,013
|
|
|
$
|
(16,229,257
|
)
|
|
$
|
(262,439
|
)
|
|
$
|
6,031,479
|
|
|
2014
|
|
2013
|
||||
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
|
|
||
Net loss
|
$
|
(1,079,205
|
)
|
|
$
|
(978,540
|
)
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
||||
Depreciation and amortization
|
85,601
|
|
|
55,857
|
|
||
Recovery (provision) for losses on accounts receivable
|
50,600
|
|
|
(8,900
|
)
|
||
Stock-based compensation
|
32,491
|
|
|
57,638
|
|
||
Changes in operating assets and liabilities
|
|
|
|
||||
(Increase) decrease in:
|
|
|
|
||||
Short-term investments
|
—
|
|
|
(202
|
)
|
||
Accounts receivable
|
(559,604
|
)
|
|
(306,849
|
)
|
||
Unbilled revenue
|
(71,710
|
)
|
|
(354,625
|
)
|
||
Inventory
|
(129,464
|
)
|
|
(49,077
|
)
|
||
Due from related party
|
(306,305
|
)
|
|
55,837
|
|
||
Prepaid expenses and other current assets
|
(135,875
|
)
|
|
92,803
|
|
||
Other assets
|
32,000
|
|
|
—
|
|
||
Increase (decrease) in:
|
|
|
|
||||
Accounts payable
|
(474,002
|
)
|
|
310,898
|
|
||
Accrued expenses
|
267,898
|
|
|
198,618
|
|
||
Deferred revenue
|
452,490
|
|
|
(110,511
|
)
|
||
Due to related party
|
(119,667
|
)
|
|
760,535
|
|
||
Interest payable, related party
|
(198,450
|
)
|
|
20,802
|
|
||
Net cash used in operating activities
|
(2,153,202
|
)
|
|
(255,716
|
)
|
||
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
|
|
||
Purchases of property and equipment
|
(55,964
|
)
|
|
(313,002
|
)
|
||
Purchases of intangible assets
|
(36,422
|
)
|
|
(323,391
|
)
|
||
Purchases of short-term investments
|
(583,720
|
)
|
|
—
|
|
||
Net cash used in investing activities
|
(676,106
|
)
|
|
(636,393
|
)
|
||
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
|
||
Payments made on demand notes payable and line of credit to related parties
|
(2,950,000
|
)
|
|
—
|
|
||
Exercise of stock options
|
6,300
|
|
|
—
|
|
||
Proceeds from sale of subsidiary common stock
|
6,000
|
|
|
—
|
|
||
Net cash provided by (used in) financing activities
|
(2,937,700
|
)
|
|
—
|
|
||
Net increase (decrease) in cash and cash equivalents
|
(5,767,008
|
)
|
|
(892,109
|
)
|
||
Cash and cash equivalents, beginning of the period
|
7,713,899
|
|
|
1,572,785
|
|
||
Cash and cash equivalents, end of the period
|
$
|
1,946,891
|
|
|
$
|
680,676
|
|
Supplemental disclosures of cash flows information:
|
|
|
|
|
|
||
Cash paid for interest
|
$
|
233,220
|
|
|
$
|
—
|
|
|
2014
|
|
2013
|
||||
Products
|
|
|
|
||||
Cogeneration
|
$
|
1,154,269
|
|
|
$
|
1,278,156
|
|
Chiller
|
790,507
|
|
|
774,509
|
|
||
Total Product Revenue
|
1,944,776
|
|
|
2,052,665
|
|
||
Services
|
|
|
|
||||
Service contracts
|
1,772,981
|
|
|
1,745,946
|
|
||
Installations
|
498,000
|
|
|
247,707
|
|
||
Total Service Revenue
|
2,270,981
|
|
|
1,993,653
|
|
||
Total Revenue
|
$
|
4,215,757
|
|
|
$
|
4,046,318
|
|
|
Three Months Ended
|
||||||
|
March 31
2014 |
|
March 31
2013 |
||||
Loss available to stockholders
|
$
|
(1,020,045
|
)
|
|
$
|
(860,393
|
)
|
|
|
|
|
||||
Weighted average shares outstanding - Basic and diluted
|
14,796,413
|
|
|
13,212,894
|
|
||
Basic and diluted loss per share
|
$
|
(0.07
|
)
|
|
$
|
(0.07
|
)
|
|
|
|
|
||||
Anti-dilutive shares underlying stock options outstanding
|
1,186,325
|
|
|
1,095,250
|
|
||
Anti-dilutive convertible debentures
|
555,556
|
|
|
75,806
|
|
Common Stock Options
|
Number of
Options
|
|
Exercise
Price Per
Share
|
|
Weighted
Average Exercise
Price
|
|
Weighted
Average Remaining
Life
|
|
Aggregate
Intrinsic
Value
|
|||||||
Outstanding, December 31, 2013
|
1,148,000
|
|
|
$1.20-$4.50
|
|
|
$
|
2.13
|
|
|
5.80 years
|
|
|
$
|
2,721,100
|
|
Granted
|
43,325
|
|
|
4.50
|
|
|
4.50
|
|
|
—
|
|
|
—
|
|
||
Exercised
|
5,000
|
|
|
1.20
|
|
|
1.20
|
|
|
—
|
|
|
—
|
|
||
Canceled and forfeited
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||
Expired
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||
Outstanding, March 31, 2014
|
1,186,325
|
|
|
$1.20-$4.50
|
|
|
$
|
2.22
|
|
|
5.73 years
|
|
|
$
|
2,704,600
|
|
Exercisable, March 31, 2014
|
919,250
|
|
|
|
|
$
|
1.90
|
|
|
|
|
$
|
2,387,075
|
|
||
Vested and expected to vest, March 31, 2014
|
1,186,325
|
|
|
|
|
$
|
2.22
|
|
|
|
|
|
$
|
2,704,600
|
|
|
Number of
Restricted
Stock
|
|
Weighted
Average
Grant Date
Fair Value
|
|||
Unvested, December 31, 2013
|
361,570
|
|
|
$
|
1.31
|
|
Granted
|
—
|
|
|
—
|
|
|
Vested
|
—
|
|
|
—
|
|
|
Forfeited
|
—
|
|
|
—
|
|
|
Unvested, March 31, 2014
|
361,570
|
|
|
$
|
1.31
|
|
Common Stock Options
|
Number of
Options
|
|
Exercise
Price Per
Share
|
|
Weighted
Average Exercise
Price
|
|
Weighted
Average Remaining
Life
|
|
Aggregate
Intrinsic
Value
|
||||||
Outstanding, December 31, 2013
|
575,000
|
|
|
$0.10-$0.50
|
|
|
$
|
0.29
|
|
|
6.44 years
|
|
$
|
120,000
|
|
Granted
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|||
Exercised
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|||
Canceled and forfeited
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|||
Expired
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|||
Outstanding, March 31, 2014
|
575,000
|
|
|
$0.10-$0.50
|
|
|
$
|
0.29
|
|
|
6.19 years
|
|
$
|
120,000
|
|
Exercisable, March 31, 2014
|
125,000
|
|
|
|
|
|
$
|
0.50
|
|
|
|
|
$
|
—
|
|
Vested and expected to vest, March 31, 2014
|
575,000
|
|
|
|
|
|
$
|
0.29
|
|
|
|
|
$
|
120,000
|
|
|
Number of
Restricted
Stock
|
|
Weighted
Average
Grant Date
Fair Value
|
|||
Unvested, December 31, 2013
|
310,000
|
|
|
$
|
0.10
|
|
Granted
|
—
|
|
|
—
|
|
|
Vested
|
—
|
|
|
—
|
|
|
Forfeited
|
—
|
|
|
—
|
|
|
Unvested, March 31, 2014
|
310,000
|
|
|
$
|
0.10
|
|
Years Ending December 31,
|
Amount
|
||
2015
|
$
|
430,144
|
|
2016
|
535,348
|
|
|
2017
|
485,040
|
|
|
2018
|
491,920
|
|
|
2019
|
499,122
|
|
|
2018 and thereafter
|
2,742,217
|
|
|
Total
|
$
|
5,183,791
|
|
•
|
John N. Hatsopoulos, the Company’s Chief Executive Officer, who is also: (a) the Chief Executive Officer and a director of American DG Energy and holds
10.7%
of American DG Energy’s common stock; (b) the Chairman of EuroSite Power; (c) a director of Ilios and holds
7.2%
of EuroSite Power’s common stock; and (d) the Chairman of GlenRose Instruments and holds
15.7%
of GlenRose Instruments’ common stock.
|
•
|
Dr. George N. Hatsopoulos, who is John N. Hatsopoulos’ brother, and is also: (a) a director of American DG Energy and holds
13.6%
of American DG Energy’s common stock; (b) an investor in Ilios and holds
3.1%
of Ilios' common stock; (c) an investor of GlenRose Instruments and holds
15.7%
of GlenRose Instruments' common stock; (d) an investor of Pharos and may be deemed to hold
24.4%
of Pharos' common stock; and (e) an investor of Levitronix and may be deemed to hold
21.4%
of Levitronix’s common stock.
|
•
|
Barry J. Sanders, who is: (a) the President and Chief Operating Officer of American DG Energy, (b) the Chief Executive Officer and a director of EuroSite Power and (c) the Chairman of Ilios.
|
•
|
Anthony S. Loumidis, the Company’s former Vice President and Treasurer, who is: (a) the former Chief Financial Officer Secretary and Treasurer of American DG Energy, (b) the former Chief Financial Officer Secretary and Treasurer of EuroSite Power, (c) the former Chief Financial Officer Secretary and Treasurer of GlenRose Instruments and (d) the former Treasurer of Ilios.
|
|
March 31, 2014
|
|
Quoted
Prices
in Active
Markets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
Assets
|
|
|
|
|
|
|
|
|
|
|
|
||||
Certificates of deposit
|
$
|
583,720
|
|
|
—
|
|
|
$
|
583,720
|
|
|
—
|
|
||
Total Assets
|
$
|
583,720
|
|
|
$
|
—
|
|
|
$
|
583,720
|
|
|
$
|
—
|
|
Inventory
|
|
$
|
17,400
|
|
Machinery and equipment
|
|
171,910
|
|
|
Computer equipment
|
|
22,070
|
|
|
Tooling
|
|
5,550
|
|
|
Developed technology
|
|
240,000
|
|
|
Goodwill
|
|
40,870
|
|
|
|
|
$
|
497,800
|
|
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
||||
Patent costs
|
$
|
469,031
|
|
|
$
|
45,648
|
|
Product certifications
|
415,706
|
|
|
93,312
|
|
||
Developed technology
|
240,000
|
|
|
16,000
|
|
||
Total
|
$
|
1,124,737
|
|
|
$
|
154,960
|
|
2014
|
|
$
|
59,917
|
|
2015
|
|
124,575
|
|
|
2016
|
|
124,575
|
|
|
2017
|
|
124,575
|
|
|
2018
|
|
118,378
|
|
|
Thereafter
|
|
417,757
|
|
|
|
|
$
|
969,777
|
|
Exhibit Number
|
|
Description of Exhibit
|
|
|
|
3.1
|
|
Amended and Restated Certificate of Incorporation
(a)
|
3.2
|
|
Amended and Restated Bylaws
(b)
|
4.1
|
|
Specimen Stock Certificate of Tecogen, Inc.
(b)
|
4.2
|
|
Form of Restricted Stock Purchase Agreement
(b)
|
4.3
|
|
Form of Stock Option Agreement
(b)
|
4.4
|
|
Indenture and Form of 6% Convertible Debenture Due 2004, dated September 24, 2001
(b)
|
4.5
|
|
Form of Securities Purchase Agreement
(c)
|
10.1
|
|
Lease Agreement between Atlantic-Waltham Investment II, LLC, and Tecogen Inc., dated May 18, 2008
(d)
|
10.2*
|
|
Second Amendment to Lease between Atlantic-Waltham Investment II, LLC, and Tecogen Inc., dated Jan 16, 2013
|
31.1*
|
|
Rule 13a-14(a) Certification of Chief Executive Officer
|
31.2*
|
|
Rule 13a-14(a) Certification of Chief Financial Officer
|
32.1*
|
|
Section 1350 Certifications of Chief Executive Officer and Chief Financial Officer
|
|
|
|
101.INS**
|
|
XBRL Instance Document
|
101.SCH**
|
|
XBRL Taxonomy Extension Schema
|
101.CAL**
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
101.DEF**
|
|
XBRL Taxonomy Extension Definition Linkbase
|
101.LAB**
|
|
XBRL Taxonomy Extension Label Linkbase
|
101.PRE**
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
*
|
Filed herewith
|
**
|
Furnished herewith
|
(a)
|
incorporated by reference to the Company's Current Report on Form 8-K, dated July 25, 2013.
|
(b)
|
incorporated by reference to the Company's Registration Statement on Form S-1, as amended, originally filed with the SEC on December 22, 2011 (Registration No. 333-178697)
|
(c)
|
incorporated by reference to the Company's Registration Statement on Form S-1, as amended, originally filed with the SEC on February 7, 2014 (Registration No. 333-193823)
|
(d)
|
incorporated by reference to exhibit 10.8 to the Company's S-1, as amended, originally filed with the SEC on December 22, 2011
|
|
TECOGEN INC.
|
|
|
(Registrant)
|
|
|
|
|
|
By:
|
/s/ John N. Hatsopoulos
|
|
Chief Executive Officer
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
By:
|
/s/ Bonnie J. Brown
|
|
Chief Financial Officer, Treasurer and Secretary
|
|
|
(Principal Financial and Accounting Officer)
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Tecogen Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
[Paragraph omitted in accordance with Exchange Act Rule 13a-14(a)];
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
|
5.
|
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Tecogen Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
[Paragraph omitted in accordance with Exchange Act Rule 13a-14(a)];
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
|
5.
|
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
1.
|
The Quarterly Report on Form 10-Q of the Company for the quarter ended
March 31, 2014
(the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78 m or 78o(d)); and
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|